Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CYCLOBENZAPRINE Cause Hypotension? 769 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 769 reports of Hypotension have been filed in association with CYCLOBENZAPRINE (Cyclobenzaprine hydrochloride). This represents 8.4% of all adverse event reports for CYCLOBENZAPRINE.

769
Reports of Hypotension with CYCLOBENZAPRINE
8.4%
of all CYCLOBENZAPRINE reports
37
Deaths
674
Hospitalizations

How Dangerous Is Hypotension From CYCLOBENZAPRINE?

Of the 769 reports, 37 (4.8%) resulted in death, 674 (87.6%) required hospitalization, and 130 (16.9%) were considered life-threatening.

Is Hypotension Listed in the Official Label?

Yes, Hypotension is listed as a known adverse reaction in the official FDA drug label for CYCLOBENZAPRINE.

What Other Side Effects Does CYCLOBENZAPRINE Cause?

Toxicity to various agents (1,854) Pain (1,494) Completed suicide (1,438) Drug hypersensitivity (1,094) Constipation (1,057) Drug ineffective (954) Drug abuse (873) Off label use (800) Fall (796) Headache (736)

What Other Drugs Cause Hypotension?

SACUBITRIL\VALSARTAN (11,718) AMLODIPINE (6,504) CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (4,694) FUROSEMIDE (4,468) TREPROSTINIL (4,412) METOPROLOL (3,213) RITUXIMAB (3,208) METFORMIN (3,116) LENALIDOMIDE (2,920) ACETAMINOPHEN (2,817)

Which CYCLOBENZAPRINE Alternatives Have Lower Hypotension Risk?

CYCLOBENZAPRINE vs CYCLOPENTOLATE CYCLOBENZAPRINE vs CYCLOPHOSPHAMIDE CYCLOBENZAPRINE vs CYCLOPHOSPHAMIDE FOR , USP CYCLOBENZAPRINE vs CYCLOPHOSPHAMIDE\DOXORUBICIN\PREDNISONE\RITUXIMAB\VINCRISTINE CYCLOBENZAPRINE vs CYCLOPHOSPHAMIDE\DOXORUBICIN\PREDNISONE\VINCRISTINE

Related Pages

CYCLOBENZAPRINE Full Profile All Hypotension Reports All Drugs Causing Hypotension CYCLOBENZAPRINE Demographics